Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000017500 | SCV000831425 | pathogenic | GLUT1 deficiency syndrome 1, autosomal recessive | 2022-08-16 | criteria provided, single submitter | clinical testing | This missense change has been observed in individual(s) with SLC2A1-related conditions (PMID: 20221955, 20687207; Invitae). It has also been observed to segregate with disease in related individuals. For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC2A1 protein function. ClinVar contains an entry for this variant (Variation ID: 16120). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 468 of the SLC2A1 protein (p.Arg468Trp). |
Gene |
RCV001548577 | SCV001768511 | uncertain significance | not provided | 2021-03-02 | criteria provided, single submitter | clinical testing | Not observed in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 20687207, 20221955, 29303961, 24847886) |
Institute of Medical Genetics and Applied Genomics, |
RCV001548577 | SCV001905594 | likely pathogenic | not provided | 2021-09-15 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000017500 | SCV000037772 | pathogenic | GLUT1 deficiency syndrome 1, autosomal recessive | 2009-10-01 | no assertion criteria provided | literature only | |
Gene |
RCV002271988 | SCV002556357 | not provided | Encephalopathy due to GLUT1 deficiency | no assertion provided | literature only | ||
Prevention |
RCV004737155 | SCV005356401 | likely pathogenic | SLC2A1-related disorder | 2024-06-21 | no assertion criteria provided | clinical testing | The SLC2A1 c.1402C>T variant is predicted to result in the amino acid substitution p.Arg468Trp. This variant has been reported in the homozygous state in individuals with glucose transporter type 1 deficiency syndrome (Klepper et al. 2009. PubMed ID: 20221955; Rotstein et al. 2010. PubMed ID: 20687207). This variant has not been reported in a large population database, indicating this variant is rare. This variant is interpreted as likely pathogenic. |